Ardelyx (ARDX) Amortizatization of Intangibles (2016 - 2026)
Ardelyx (ARDX) reported Amortizatization of Intangibles of $362000.0 for Q1 2026, down 83.05% on a YoY basis from $2.1 million in Q1 2025, and down 82.6% quarter-over-quarter from $2.1 million in Q4 2025.
Ardelyx (ARDX) Amortizatization of Intangibles (2016 - 2026) Analysis & Trends
Ardelyx has reported Amortizatization of Intangibles for 11 years, with the latest figure at $362000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortizatization of Intangibles fell 83.05% year-over-year to $362000.0; the trailing twelve-month figure through Mar 2026 stood at $7.2 million (up 63.61% YoY), and the FY2025 full-year result was $9.0 million, up 123.5% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $362000.0, down from $2.1 million in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $2.5 million in Q3 2025, with the low at -$608000.0 in Q4 2022.
- Historically, Amortizatization of Intangibles has averaged $1.1 million across 5 years, with a median of $1.0 million in 2024.
- The largest YoY upside for Amortizatization of Intangibles was 1102.86% in 2022 against a maximum downside of 173.43% in 2022.
- Ardelyx's Amortizatization of Intangibles stood at -$608000.0 in 2022, then surged by 285.36% to $1.1 million in 2023, then slipped by 8.16% to $1.0 million in 2024, then soared by 101.06% to $2.1 million in 2025, then tumbled by 82.6% to $362000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $362000.0 (Q1 2026), $2.1 million (Q4 2025), and $2.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn | 362,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 362,000.00 |
| Mar 31, 2026 | 362,000.00 |
| Dec 31, 2025 | 2.08 Mn |
| Dec 31, 2025 | 2.08 Mn |
| Sep 30, 2025 | 2.45 Mn |
| Sep 30, 2025 | 2.45 Mn |
| Jun 30, 2025 | 2.29 Mn |
| Jun 30, 2025 | 2.29 Mn |
| Mar 31, 2025 | 2.14 Mn |
| Mar 31, 2025 | 2.14 Mn |
| Dec 31, 2024 | 1.04 Mn |
| Dec 31, 2024 | 1.04 Mn |
| Sep 30, 2024 | -438,000.00 |
| Sep 30, 2024 | -438,000.00 |
| Jun 30, 2024 | 1.66 Mn |
| Jun 30, 2024 | 1.66 Mn |
| Mar 31, 2024 | 1.75 Mn |
| Mar 31, 2024 | 1.75 Mn |
| Dec 31, 2023 | 1.13 Mn |
| Dec 31, 2023 | 1.13 Mn |